Skip to Content

Notice

National Cancer Institute; Notice of Closed Meeting

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. appendix 2), notice is hereby given of the meeting of the President's Cancer Panel.

The meeting will be closed to the public in accordance with the provisions set forth in section 552b(c)(9)(B), Title 5 U.S.C., as amended, because the premature disclosure of information and the discussions would be likely to significantly frustrate implementation of recommendations.

Name of Committee: President's Cancer Panel.

Date: March 30, 2005.

Time: 1 p.m. to 3 p.m.

Agenda: The Panel will review the first draft of the upcoming PCP annual report on “Translating Research to Reduce the Burden of Cancer.”

Place: National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, Building 6116, Room 212, Bethesda, MD 20892, (Teleconference).

Contact Person: Abby B. Sandler, PhD, Executive Secretary, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, Building 6116, Room 212, Bethesda, MD 20892, 301/451-9399.

This meeting is being published less than 15 days prior to the meeting due to scheduling conflicts.

Any interested person may file written comments with the committee by forwarding the comments to the Contact Person listed on this Notice. The comments should include the name, address, telephone number and, when applicable, the business or professional affiliation of the interested person.

Information is also available on the Institute's/Center's home page: http://www.deainfo.nci.nih.gov/​advisory/​pcp/​pcp.htm, where an agenda and any additional information for the meeting will be posted when available.

Start Signature

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93,397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

Start Printed Page 12890

Dated: March 10, 2005.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory Committee Policy.

End Signature End Preamble

[FR Doc. 05-5163 Filed 3-15-05; 8:45 am]

BILLING CODE 4140-01-M